Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1997-6-19
pubmed:abstractText
Apoptosis is postulated to be involved as an anti-viral immune mechanism by killing infected cells before viral replication has occurred. The Fas-Fas ligand interaction is a powerful regulator of T cell apoptosis and could potentially act as a potent anti-viral immune mechanism against T cell tropic virus such as human immunodeficiency virus (HIV). We investigated the status of Fas ligand in peripheral blood mononuclear cells (PBMCs) obtained from persons infected with HIV. We found that monocytes in freshly isolated PBMCs from healthy individuals possess cell surface Fas ligand. In contrast, monocytes in freshly isolated PBMCs from HIV-infected patients had no detectable Fas ligand on the cell surface. Consistent with these findings of surface expression, Fas ligand activity was deficient in the cells from HIV-infected persons. The effect of replacing Fas ligand activity on HIV production by patients' cells was assessed in an in vitro assay. The addition of a functional anti-Fas antibody to PBMCs from HIV-infected individuals inhibited viral production by greater than 90% without affecting lymphocytic function. These findings suggest the possibility of a new therapeutic modality for the treatment of HIV-infected individuals based on the reconstitution of Fas ligand activity.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-1321290, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-1339309, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-1533443, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-1702216, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-2161559, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7500022, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7528780, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7529365, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7536768, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7539037, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7539892, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7689176, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7816094, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7884855, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7884884, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-7905630, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8124715, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8397406, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8523526, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8609385, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8615027, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8652808, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8676488, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8676520, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8752920, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8763993, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8816396, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8838700, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8924258, http://linkedlifedata.com/resource/pubmed/commentcorrection/9159165-8971002
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5860-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:9159165-Antigens, CD, pubmed-meshheading:9159165-Antigens, CD95, pubmed-meshheading:9159165-Cell Line, pubmed-meshheading:9159165-Cells, Cultured, pubmed-meshheading:9159165-DNA Primers, pubmed-meshheading:9159165-Fas Ligand Protein, pubmed-meshheading:9159165-Flow Cytometry, pubmed-meshheading:9159165-HIV, pubmed-meshheading:9159165-HIV Core Protein p24, pubmed-meshheading:9159165-HIV Infections, pubmed-meshheading:9159165-HIV Seronegativity, pubmed-meshheading:9159165-Humans, pubmed-meshheading:9159165-Lymphocytes, pubmed-meshheading:9159165-Membrane Glycoproteins, pubmed-meshheading:9159165-Monocytes, pubmed-meshheading:9159165-Polymerase Chain Reaction, pubmed-meshheading:9159165-RNA, Messenger, pubmed-meshheading:9159165-Reference Values, pubmed-meshheading:9159165-Transcription, Genetic, pubmed-meshheading:9159165-Tumor Cells, Cultured, pubmed-meshheading:9159165-Virus Replication
pubmed:year
1997
pubmed:articleTitle
Fas ligand deficiency in HIV disease.
pubmed:affiliation
The Institute of Pathology, Case Western Reserve University, Biomedical Research Building, 2109 Adelbert Road, Cleveland, OH 44106-4943, USA.
pubmed:publicationType
Journal Article